Discover

COO
The Cooper Companies, Inc.
61.20
2 x 56.16
2 x 66.03
bid
ask
-
0.45
0.72%
12:25 PM
timesize
Ytd-25.32%
1y-17.87%
60.46
day range
61.73
53.27
52 week range
84.32
Open61.28Prev Close61.65Low60.46High61.73Mkt Cap11.64B
Vol485.68KAvg Vol3.34MEPS2.91P/E21.03Forward P/E13.14
Beta0.83Short Ratio1.62Inst. Own111.17%DividendN/ADiv YieldN/A
Ex Div Date07-26Earning09-0950-d Avg62.23200-d Avg69.581yr Est65.80
Earning
DateForEstimateReportedSurprisesurprise %
2026-12-032026-101.07N/AN/AN/A
2026-09-092026-071.121.150.032.68%
2026-06-042026-041.11.210.1110.00%
2026-03-052026-011.031.10.076.80%
2025-12-042025-101.111.150.043.60%
2025-08-272025-071.071.10.032.80%
Upgrade / Downgrade
DateFirmActionFromTo
2026-10-07BarclaysUpgradeEqual-Weight
2026-09-15NeedhamUpgradeBuyBuy
2026-09-11MizuhoUpgradeOutperformOutperform
2026-09-10William BlairDowngradeOutperformMarket Perform
2026-09-10Wells FargoUpgradeEqual-WeightEqual-Weight
2026-09-10StifelUpgradeBuyBuy
Profile
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Insider Holder
DateNameRelationQuantityDescription
2026-01-07ANDREWS BRIAN GChief Financial Officer30.73KConversion of Exercise of derivative security
2026-03-31JAY COLLEEN EDirector39.91KConversion of Exercise of derivative security
2025-03-31KOZY WILLIAM ADirector31.15KConversion of Exercise of derivative security
2026-09-15KURZIUS LAWRENCE ERIKDirector31.10KPurchase
2026-01-07MCBRIDE DANIEL GChief Operating Officer163.85KConversion of Exercise of derivative security
2026-09-13ROSEBROUGH WALTER M JRDirector0.00Purchase
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29Blackrock Inc.15.03M926.57M7.90%
2026-06-29Vanguard Capital Management LLC12.76M786.58M6.71%
2026-06-29State Street Corporation8.89M548.23M4.68%
2026-06-29Vanguard Portfolio Management LLC8.67M534.49M4.56%
2026-06-29T. Rowe Price Investment Management, Inc.7.43M458.03M3.91%
2026-06-29Browning West Lp7.20M443.60M3.78%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund6.19M381.65M3.26%
2026-06-29VANGUARD INDEX FUNDS-Vanguard 500 Index Fund5.06M311.76M2.66%
2026-06-29VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund4.47M275.83M2.35%
2026-06-29T. Rowe Price Mid-Cap Growth Fund, Inc.3.88M239.43M2.04%
2026-09-29Invesco Exchange-Traded Fund Trust-Invesco S&P 500 Equal Weight ETF3.08M189.98M1.62%
2026-06-29VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund2.83M174.75M1.49%
Dividend
DividendDate
0.032023-07-27
0.032023-07-26
0.032023-01-20
0.032022-07-26
0.032022-01-20
0.032021-07-26
Split
SplitDate
4 : 12024-02-20
2 : 12002-11-25
1 : 31995-09-22
110 : 1001983-09-26